Yang W - Search Results

1

Is myasthenia gravis a contraindication for botulinum toxin?

Ma Q, Ran H, Ou C, Liu X, Lu Y, Huang H, Yang W, Yu L, Chen P, Huang X, Qiu L, Lin Z, Huang Z, Liu W. Ma Q, et al. Among authors: yang w. J Clin Neurosci. 2022 Jan;95:44-47. doi: 10.1016/j.jocn.2021.11.010. Epub 2021 Dec 4. J Clin Neurosci. 2022. PMID: 34929650 Review.

2

[Complications following Nd: YAG laser posterior capsulotomy].

Lin ZD, Yang WH, Liu YZ. Lin ZD, et al. Among authors: yang wh. Zhonghua Yan Ke Za Zhi. 1994 Sep;30(5):325-7. Zhonghua Yan Ke Za Zhi. 1994. PMID: 7805529 Chinese.

3

AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.

Lu Y, Ran H, Yang W, Ma Q, Qiu L, Ou C, Chen P, Lin Z, Liu W. Lu Y, et al. Among authors: yang w. Neuromuscul Disord. 2020 Jul;30(7):534-538. doi: 10.1016/j.nmd.2020.03.012. Epub 2020 Apr 13. Neuromuscul Disord. 2020. PMID: 32387283 Review.

4

Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients.

Ma Q, Ran H, Li Y, Lu Y, Liu X, Huang H, Yang W, Yu L, Chen P, Huang X, Qiu L, Lin Z, Ou C, Liu W. Ma Q, et al. Among authors: yang w. Clin Immunol. 2020 Sep;218:108492. doi: 10.1016/j.clim.2020.108492. Epub 2020 Jun 8. Clin Immunol. 2020. PMID: 32526271

5

Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses.

Huang H, Ran H, Liu X, Yu L, Qiu L, Lin Z, Ou C, Lu Y, Yang W, Liu W. Huang H, et al. Among authors: yang w. Int Immunopharmacol. 2021 Apr;93:107434. doi: 10.1016/j.intimp.2021.107434. Epub 2021 Feb 5. Int Immunopharmacol. 2021. PMID: 33556668

6

Clinical evaluation of efficacy of leflunomide combined with low-dose prednisone for treatment of myasthenia gravis.

Huang X, Qiu L, Lu Y, Chen J, Yang W, Ou C, Ran H, Liu W. Huang X, et al. Among authors: yang w. Acta Neurol Belg. 2023 Feb;123(1):153-160. doi: 10.1007/s13760-021-01769-0. Epub 2021 Aug 19. Acta Neurol Belg. 2023. PMID: 34410678

7

[Current status of diagnosis and treatment of chronic lymphocytic leukemia in China: A national multicenter survey research].

Xu W, Yi SH, Feng R, Wang X, Jin J, Mi JQ, Ding KY, Yang W, Niu T, Wang SY, Zhou KS, Peng HL, Huang L, Liu LH, Ma J, Luo J, Su LP, Bai O, Liu L, Li F, He PC, Zeng Y, Gao D, Jiang M, Wang JS, Yao HX, Qiu LG, Li JY. Xu W, et al. Among authors: yang w. Zhonghua Xue Ye Xue Za Zhi. 2023 May 14;44(5):380-387. doi: 10.3760/cma.j.issn.0253-2727.2023.05.005. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 37550187 Free PMC article. Chinese.

8

Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas.

Zhang H, Ouyang Y, Zhang H, Zhang Y, Su R, Zhou B, Yang W, Lei Y, Huang B. Zhang H, et al. Among authors: yang w. Clin Radiol. 2024 May;79(5):e682-e691. doi: 10.1016/j.crad.2024.01.030. Epub 2024 Feb 8. Clin Radiol. 2024. PMID: 38402087

9

Research status of facial nerve repair.

Huang H, Lin Q, Rui X, Huang Y, Wu X, Yang W, Yu Z, He W. Huang H, et al. Among authors: yang w. Regen Ther. 2023 Oct 7;24:507-514. doi: 10.1016/j.reth.2023.09.012. eCollection 2023 Dec. Regen Ther. 2023. PMID: 37841661 Free PMC article. Review.

10

[Extracapsular cataract extraction for highly myopic patients].

Yang WH. Yang WH. Zhonghua Yan Ke Za Zhi. 1990 Nov;26(6):337-9. Zhonghua Yan Ke Za Zhi. 1990. PMID: 2086151 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31,544 results

Search Page